Article | August 23, 2022

Never Miss Another Re-Consent: The Benefits Of An Integrated eSource And eConsent Solution

Source: CRIO

By Raymond Nomizu, JD, CEO & Co-founder at CRIO

GettyImages-537316778 consent

There is a common problem with most eConsent solutions: they don’t solve the “Re-consent Problem." In the majority of clinical trials, sponsors make mid-study amendments to the protocol, which necessitate a new version of the Informed Consent Form (ICF). ICH-GCP principles require that the investigator execute the new version of the ICF with an enrolled patient prior to performing any procedures under the new amendment – this re-consent is usually done at the outset of the patient’s next visit.

While a stand-alone eConsent solution can track versioning across subjects, it does not “know” when a patient is performing their next visit. Therefore, it's easy for site staff to forget to perform the re-consent - especially given that most sites are quite busy, and the fact that coordinators are often juggling multiple studies at a time.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader